glucagon like peptide 1 glp 1 receptor agonist medications Glucagon-like peptide-1 receptor: mechanisms and advances in therapy 20 Companies in Glucagon-Like Peptide-1
Description
But of course, GLP was another one early identified as well

Gastrointestinal adverse events of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis

This rapid degradation is the primary reason that GLP-1 receptor agonist drugs require structural modifications such as DPP-4 resistance mutations, albumin binding, or Fc fusion to achieve a pharmacologically useful duration of action

Frontiers in Endocrinology
How do GLP-1 medications improve blood sugar levels in people without diabetes

Liraglutide changes postprandial responses of gut hormones involved in the regulation of gallbladder motility
